Page last updated: 2024-08-23

rafoxanide and Skin Neoplasms

rafoxanide has been researched along with Skin Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, W; Ding, Y; Dong, C; Hai, Q; He, YH; Ke, K; Kung, HF; Lei, L; Leung, KS; Li, H; Li, L; Lin, MC; Liu, X; Qin, Y; Shi, A; Shi, X; Wong, MH; Yao, H; Zhu, Y	1

Other Studies

1 other study(ies) available for rafoxanide and Skin Neoplasms

Article	Year
Discovery of rafoxanide as a dual CDK4/6 inhibitor for the treatment of skin cancer. Oncology reports, 2018, Volume: 40, Issue:3 Topics: Animals; Antinematodal Agents; Antineoplastic Agents; Apoptosis; Biomarkers, Tumor; Cell Proliferation; Cyclin-Dependent Kinase 4; Cyclin-Dependent Kinase 6; Drug Discovery; Female; Gene Expression Regulation, Enzymologic; High-Throughput Screening Assays; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Protein Kinase Inhibitors; Rafoxanide; Skin Neoplasms; Small Molecule Libraries; Tumor Cells, Cultured; Xenograft Model Antitumor Assays	2018

Article

Year

Discovery of rafoxanide as a dual CDK4/6 inhibitor for the treatment of skin cancer.

Oncology reports, 2018, Volume: 40, Issue:3

Topics: Animals; Antinematodal Agents; Antineoplastic Agents; Apoptosis; Biomarkers, Tumor; Cell Proliferation; Cyclin-Dependent Kinase 4; Cyclin-Dependent Kinase 6; Drug Discovery; Female; Gene Expression Regulation, Enzymologic; High-Throughput Screening Assays; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Protein Kinase Inhibitors; Rafoxanide; Skin Neoplasms; Small Molecule Libraries; Tumor Cells, Cultured; Xenograft Model Antitumor Assays

2018